文献速递妇科

妇科手术后再次入院:良性与恶性指征手术的比较

Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.
PubMed 文献 · Obstet Gynecol · 2017-01-01

该回顾性队列研究利用美国国家手术质量改进计划数据库2011年1月1日至2012年12月31日的数据,比较良性与恶性妇科指征手术后30天再入院率及相关危险因素。恶性指征再入院率8.2%(623/7,641),良性约3%(1,444/46,718)(P<.01);子宫癌、卵巢癌、宫颈癌再入院风险均高于良性指征,术前状况差和主要并发症为独立危险因素。

要点

  • 恶性妇科手术后30天再入院率8.2%(623/7,641),良性约3%(1,444/46,718)(P<.01)。
  • 卵巢癌再入院率10.9%(OR 3.82,95%CI 3.29-4.45),宫颈癌10.1%(OR 3.51,95%CI 2.71-4.53),子宫癌6.6%(OR 2.21,95%CI 1.95-2.51)。
  • 恶性手术独立危险因素:术前状况差(OR 1.49,95%CI 1.17-1.90)、主要并发症(OR 17.84,95%CI 14.19-22.43)。

核心结论

  • 妇科手术中,肿瘤指征手术的再入院率约为良性指征手术的2.8倍。
  • 校正模型中,术前状况差和手术并发症仍是妇科癌症患者再入院率较高的独立危险因素。

研究设计与样本

  • 回顾性队列研究,使用美国国家手术质量改进计划数据库2011年1月1日至2012年12月31日数据。
  • 纳入良性及恶性妇科疾病手术后患者,收集手术因素、围手术期特征、手术并发症及30天再入院情况。

主要发现

  • 良性指征再入院约3%(1,444/46,718),恶性指征8.2%(623/7,641)(P<.01)。
  • 与良性手术指征相比,子宫癌再入院率6.6%(OR 2.21,95%CI 1.95-2.51),卵巢癌10.9%(OR 3.82,95%CI 3.29-4.45),宫颈癌10.1%(OR 3.51,95%CI 2.71-4.53)。
  • 妇科癌症手术再入院独立危险因素:术前状况差(OR 1.49,95%CI 1.17-1.90)、主要并发症(OR 17.84,95%CI 14.19-22.43)。
  • 良性指征手术再入院独立危险因素:合并症(OR 1.36,95%CI 1.18-1.57)、手术时间60分钟或以上(以15-59分钟为参照,OR 1.37,95%CI 1.14-1.63)、主要并发症(OR 53.91,95%CI 46.98-61.85)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare 30-day postsurgical readmission rates and associated risk factors for readmission among women undergoing gynecologic surgery for benign and malignant conditions. METHODS: In a retrospective cohort study, we identified patients after surgery for benign and malignant gynecologic conditions in the National Surgical Quality Improvement Program database between January 1, 2011, and December 31, 2012. Data collected included surgical factors, perioperative characteristics, surgical complications, and 30-day readmissions. The primary study outcome was readmission rates after gynecologic surgery for benign and oncologic conditions. Secondary study outcomes were risk factors associated with readmission among gynecologic surgeries performed for benign and oncologic conditions. RESULTS: Approximately 3% (1,444/46,718) compared with 8.2% (623/7,641) of patients who underwent gynecologic surgery for benign and malignant indications, respectively, were readmitted (P<.01). Compared with patients with benign surgical indications, those with uterine cancer (readmission rate 6.6%; odds ratio [OR] 2.21, 95% CI 1.95-2.51), ovarian cancer (readmission rate 10.9%; OR 3.82, 95% CI 3.29-4.45), and cervical cancer (readmission rate 10.1%; OR 3.51, 95% CI 2.71-4.53) were more likely to be readmitted. In multivariable models, independent risk factors for readmission for gynecologic cancer surgery included worse preoperative conditions (OR 1.49, 95% CI 1.17-1.90) and major complications (OR 17.84, 95% CI 14.19-22.43). In comparison, independent risk factors for readmission after surgery for benign indications included comorbid conditions (OR 1.36, 95% CI 1.18-1.57), operative time (15-59 minutes: referent; 60 minutes or greater: 1.37, 95% CI 1.14-1.63) and major complications (OR 53.91, 95% CI 46.98-61.85). CONCLUSION: Among gynecologic surgeries, those performed for oncologic indications were associated with readmission rates 2.8 times that of surgeries performed for benign indications. In adjusted models, worse preoperative conditions and surgical complications remained independent risk factors associated with the higher rate of readmission among patients with gynecologic cancer.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Cory L, Latif N, Brensinger C, et al. Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications. Obstet Gynecol. 2017. PMID: 28697106. doi:10.1097/AOG.0000000000002141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。